Hydrodynamics- and ultrasound-based transfection of heart with naked plasmid DNA

Human Gene Therapy

Volumn 18, Issue 12, 2007, Pages 1233-1243

  De Carvalho, Leonardo Pinto ^a,b   Takeshita, Daniela ^a   Carillo, Bruno A ^a   Lisbôa, Bianca Cristina Garcia ^a   Molina, Gustavo ^a   Beutel, Abram ^a   Yasumura, Eduardo Gallatti ^a   Takiya, Christina Maeda ^c   Valero, Valderez Bastos ^a   De Campos Jr , Ruy Ribeiro ^a   Dohmann, Hans Fernando ^b   Han, Sang Won ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL PRÓ CARDÍACO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; EOSIN; HEMATOXYLIN; PHOSPHATE BUFFERED SALINE; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CLAMP; CONTROLLED STUDY; DNA TRANSFECTION; ELECTROCARDIOGRAPHY; EPICARDIUM; HEART; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HISTOLOGY; HYDRODYNAMICS; MALE; NONHUMAN; RAT; STAINING; ULTRASOUND;

ANIMALS; BETA-GALACTOSIDASE; DNA; ELECTROCARDIOGRAPHY; GENES, REPORTER; GENETIC VECTORS; HEART; MYOCARDIUM; PLASMIDS; RATS; TRANSFECTION; ULTRASONICS;

ANIMALIA; RATTUS;

EID: 37149050601     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.063     Document Type: Article

References (36)

1. AOKI, M., MORISHITA, R., TANIYAMA, Y., KIDA, I., MORIGUCHI, A., MATSUMOTO, K., NAKAMURA, T., KANEDA, Y., HIGAKI, J., and OGIHARA, T. (2000). Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther. 7, 417-427.
2. AY, T., HAVAUX, X., VAN CAMP, G., CAMPANELLI, B., GISELLU, G., PASQUET, A., DENEF, J.F., MELIN, J.A., and VANOVERSCHELDE, J.L. (2001). Destruction of contrast microbubbles by ultrasound: Effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation 104, 461-466.
3. BESSIS, N., GARCIACOZAR, F.J., and BOISSIER, M.C. (2004). Immune responses to gene therapy vectors: Influence on vector function and effector mechanisms. Gene Ther. 11(Suppl. 1), S10-S17.
4. BRAYMAN, A.A., COPPAGE, M.L., VAIDYA, S., and MILLER, M.W. (1999). Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound. Ultrasound Med. Biol. 25, 999-1008.
5. CHEN, S., SHOHET, R.V., BEKEREDJIAN, R., FRENKEL, P., and GRAYBURN, P.A. (2003). Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J. Am. Coll. Cardiol. 42, 301-308.
6. DUVSHANI-ESHET, M., BARUCH, L., KESSELMAN, E., SHIMONI, E., and MACHLUF, M. (2006). Therapeutic ultrasound-mediated DNA to cell and nucleus: Bioeffects revealed by confocal and atomic force microscopy. Gene Ther. 13, 163-172.
7. FERIL, L.B., Jr., and KONDO, T. (2006). Ultrasound liberates nitric oxide (NO) from the caged NO compound N,N′-bis(carboxymethyl)-N, N′-dinitroso-p-phenylenediamine sodium salt. Ultrason. Sonochem. 13, 397-400.
8. HAGSTROM, J.E., HEGGE, J., ZHANG, G., NOBLE, M., BUDKER, V., LEWIS, D.L., HERWEIJER, H., and WOLFF, J.A. (2004). A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol. Ther. 10, 386-398.
9. HAMMOND, H.K., and MCKIRNAN, M.D. (2001). Angiogenic gene therapy for heart disease: A review of animal studies and clinical trials. Cardiovasc. Res. 49, 561-567.
10. HERWEIJER, H., and WOLFF, J.A. (2003). Progress and prospects: Naked DNA gene transfer and therapy. Gene Ther. 10, 453-458.
11. HSU, W.H., BELLIN, S.I., DELLMANN, H.D., and HANSON, C.E. (1986). Xylazine-ketamine-induced anesthesia in rats and its antagonism by yohimbine. J. Am. Vet. Med. Assoc. 189, 1040-1043.
12. HSU, W.H., SCHAFFER, D.D., and HANSON, C.E. (1987). Effects of tolazoline and yohimbine on xylazine-induced central nervous system depression, bradycardia, and tachypnea in sheep. J. Am. Vet. Med. Assoc. 190, 423-426.
13. HUNT, S.A., ABRAHAM, W.T., CHIN, M.H., FELDMAN, A.M., FRANCIS, G.S., GANIATS, T.G., JESSUP, M., KONSTAM, M.A., MANCINI, D.M., MICHL, K., OATES, J.A., RAHKO, P.S., SILVER, M.A., STEVENSON, L.W., YANCY, C.W., ANTMAN, E.M., SMITH, S.C., Jr., ADAMS, C.D., ANDERSON, J.L., FAXON, D.P., FUSTER, V., HALPERIN, J.L., HIRATZKA, L.F., JACOBS, A.K., NISHIMURA, R., ORNATO, J.P., PAGE, R.L., and RIEGEL, B. (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult [ACC/AHA Practice Guidelines]. Circulation 112, e154-e235.
14. ISNER, J.M. (2002). Myocardial gene therapy. Nature 415, 234-239.
15. KONDO, I., OHMORI, K., OSHITA, A., TAKEUCHI, H., FUKE, S., SHINOMIYA, K., NOMA, T., NAMBA, T., and KOHNO, M. (2004). Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: The first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 44, 644-653.
16. LEE, R.J., SPRINGER, M.L., BLANCO-BOSE, W.E., SHAW, R., URSELL, P.C., and BLAU, H.M. (2000). VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 102, 898-901.
17. 165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804.
18. MILLER, D.L., and QUDDUS, J. (2000). Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc. Natl. Acad. Sci. U.S.A. 97, 10179-10184.
19. MILOWSKA, K., and GABRYELAK, T. (2007). Reactive oxygen species and DNA damage after ultrasound exposure. Biomol. Eng. 24, 263-267.
20. MULLER, O.J., KATUS, H.A., and BEKEREDJIAN, R. (2007). Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc. Res. 73, 453-462.
21. NEWMAN, C.M., and BETTINGER, T. (2007). Gene therapy progress and prospects: Ultrasound for gene transfer. Gene Ther. 14, 465-475.
22. PISLARU, S.V., PISLARU, C., KINNICK, R.R., SINGH, R., GULATI, R., GREENLEAF, J.F., and SIMARI, R.D. (2003). Optimization of ultrasound-mediated gene transfer: Comparison of contrast agents and ultrasound modalities. Eur. Heart J. 24, 1690-1698.
23. RAHIM, A.A., TAYLOR, S.L., BUSH, N.L., TER HAAR, G.R., BAMBER, J.C., and PORTER, C.D. (2006). Spatial and acoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound. J. Gene Med. 8, 1347-1357.
24. SCHWARZ, E.R., SPEAKMAN, M.T., PATTERSON, M., HALE, S.S., ISNER, J.M., KEDES, L.H., and KLONER, R.A. (2000). Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat: Angiogenesis and angioma formation. J. Am. Coll. Cardiol. 35, 1323-1330.
25. SKYBA, D.M., PRICE, R.J., LINKA, A.Z., SKALAK, T.C., and KAUL, S. (1998). Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 98, 290-293.
26. SOMIA, N., and VERMA, I.M. (2000). Gene therapy: Trials and tribulations. Nat. Rev. Genet. 1, 91-99.
27. SYMES, J.F. (2001). Gene therapy for ischemic heart disease: Therapeutic potential. Am. J. Cardiovasc. Drugs 1, 159-166.
28. SYMES, J.F., LOSORDO, D.W., VALE, P.R., LATHI, K.G., ESAKOF, D.D., MAYSKIY, M., and ISNER, J.M. (1999). Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann. Thorac. Surg. 68, 830-836.
29. TANAKA, K., GOTOH, T.M., AWAZU, C., and MORITA, H. (2005). Regional difference of blood flow in anesthetized rats during reduced gravity induced by parabolic flight. J. Appl. Physiol. 99, 2144-2148.
30. TANIYAMA, Y., TACHIBANA, K., HIRAOKA, K., AOKI, M., YAMAMOTO, S., MATSUMOTO, K., NAKAMURA, T., OGIHARA, T., KANEDA, Y., and MORISHITA, R. (2002). Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9, 372-380.
31. TIO, R.A., TKEBUCHAVA, T., SCHEUERMANN, T.H., LEBHERZ, C., MAGNER, M., KEARNY, M., ESAKOF, D.D., ISNER, J.M., and SYMES, J.F. (1999). Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum. Gene Ther. 10, 2953-2960.
32. 165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102, 965-974.
33. WAGNER, G.S., ROE, C.R., LIMBIRD, L.E., ROSATI, R.A., and WALLACE, A.G. (1973). The importance of identification of the myocardial-specific isoenzyme of creatine phosphokinase (MB form) in the diagnosis of acute myocardial infarction. Circulation 47, 263-269.
34. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
35. WORLD HEALTH ORGANIZATION (2003). World Health Report, 2003: Shaping the Future (World Health Organization, Geneva, Switzerland). Available at http://www.who.int/whr/2003/en/whr03_en.pdf (accessed November 2007).
36. ZHANG, G., GAO, X., SONG, Y.K., VOLLMER, R., STOLZ, D.B., GASIOROWSKI, J.Z., DEAN, D.A., and LIU, D. (2004). Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther. 11, 675-682